Two Pandemics, One Challenge—Leveraging Molecular Test Capacity of Tuberculosis Laboratories for Rapid COVID-19 Case-Finding
In many settings, the ongoing coronavirus disease (COVID-19) pandemic coincides with other major public health threats, in particular tuberculosis. Using tuberculosis (TB) molecular diagnostic infrastructure, which has substantially expanded worldwide in recent years, for COVID-19 case-finding might...
Main Authors: | Susanne Homolka, Laura Paulowski, Sönke Andres, Doris Hillemann, Ruwen Jou, Gunar Günther, Mareli Claassens, Martin Kuhns, Stefan Niemann, Florian P. Maurer |
---|---|
Format: | Article |
Language: | English |
Published: |
Centers for Disease Control and Prevention
2020-11-01
|
Series: | Emerging Infectious Diseases |
Subjects: | |
Online Access: | https://wwwnc.cdc.gov/eid/article/26/11/20-2602_article |
Similar Items
-
Leveraging PEPFAR-Supported Health Information Systems for COVID-19 Pandemic Response
by: Muzna Mirza, et al.
Published: (2022-11-01) -
Covid-19 immune mechanisms: A systematic review
by: Shalini Gandhi, et al.
Published: (2020-01-01) -
Four cases of coronavirus disease 2019 in the early stage of pandemic of South Korea: a single public hospital experience
by: Mi Young Ahn, et al.
Published: (2020-07-01) -
Understanding the unusual viral outbreak: Coronavirus disease 2019
by: Tarun Kumar Suvvari, et al.
Published: (2020-01-01) -
Coronavirus Disease 2019: A Brief Review of the Clinical Manifestations and Pathogenesis to the Novel Management Approaches and Treatments
by: Omid Kooshkaki, et al.
Published: (2020-10-01)